1 Day
Source:
USA TODAY
_1777370220974_847775619.png&w=48&q=75){kind=small}
White House: Trump did not receive Eli Lilly obesity drug
Eli Lilly provided an experimental obesity and diabetes drug to an unidentified 79-year-old man through the FDA's compassionate use program, raising questions about the rarity of such exclusive access. The drug, retratrutide, is in late-stage trials and shows promise comparable to bariatric surgery for weight loss. The patient's connection and the circumstances of the access have sparked speculation, but the White House denied any involvement with President Trump receiving the drug.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)